Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company based in Liaoyuan, Jilin Province, and operates as a wholly-owned subsidiary of Guangdong Zhongsheng Pharmaceutical. The company specializes in the research, development, and large-scale manufacturing of Traditional Chinese Medicines (TCM) and chemical drug products. Its portfolio primarily addresses therapeutic areas such as cardiovascular health, respiratory diseases, and anti-inflammatory treatments, featuring products like Compound Salvia Miltiorrhiza Tablets. Jilin Zhongsheng maintains modern, GMP-certified production facilities that support the parent company's supply chain and market reach in Northern China. The company is recognized for its efforts in the modernization of botanical extracts and the industrialization of high-quality herbal medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Zhongsheng Pharmaceutical.